Fundraising Fox
/Companies
Sign in

Tasca Therapeutics

Cambridge, US · Founded 2021 · 3 known investors

Find your way into Tasca Therapeutics

Sign up to find every way you can get introduced to Tasca Therapeutics

  • Your email: who you already know at Tasca Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Tasca Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Unlocking post-translational protein modification using chemical biology and computational approaches to develop drugs for previously undruggable oncology targets.

Biotech

Founders & leadership

Tasca Therapeutics was founded in 2021 by Xu Wu.

XW
Xu WuFounder

Board

DFDavid Fallace
David FallaceBoard directorManaging Partner at Cure Ventures
SLSeth Lieblich
Seth LieblichBoard directorInvestment Team at 8VC
MAMichael Aberman
Michael AbermanBoard directorPartner at SOSV
DKDrew King
Drew KingBoard directorCFO and Partner at Cure Ventures
MCMilenko Cicmil
Milenko CicmilBoard directorVenture Partner at Cure Ventures
PT
Praveen TipirneniBoard director

Investors · 3

Cure Ventureslisted by Cure VenturesBoston

How we know: Cure Ventures's portfolio page · board seat on SEC Form D · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

SOSVinferredNew York · $30K – $550Kvia Michael Aberman · board

How we know: board seat on SEC Form D · Not right? Tell us

Funding

SEC filings, press & company announcements

$100.1M disclosed across 2 rounds · 2024

▶$48.1MraisedDec 2025 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Praveen TipirneniDirector
  • David FallaceDirector
  • Seth LieblichDirector
  • Michael AbermanDirector
  • Drew KingExecutive Officer
  • Milenko CicmilExecutive Officer, Director
  • Xu WuDirector
Offering amount
$70.2M
Amount sold
$48.1M
First sale
Nov 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Tasca Therapeutics do?
Unlocking post-translational protein modification using chemical biology and computational approaches to develop drugs for previously undruggable oncology targets.
Who founded Tasca Therapeutics?
Tasca Therapeutics was founded by Xu Wu in 2021.
Who are Tasca Therapeutics's investors?
Tasca Therapeutics's investors include 8VC, Cure Ventures, SOSV.
How much funding has Tasca Therapeutics raised?
Tasca Therapeutics has disclosed $100.1M raised across 2 rounds.
Where is Tasca Therapeutics headquartered?
Tasca Therapeutics is headquartered in Cambridge, US.